APA KATA PAKAR-PAKAR?
Researchers at Ohio State University Medical Center (Columbus, Ohio), University of Kuopio (Kuopio, Finland), and Creighton University Medical Center (Omaha, Neb.) have shown that OptiBerry significantly inhibits angiogenesis both in vitro and in vivo, thus offering potential benefit in the treatment of related disorders such as cancer and inflammation. The studies were published in Free Radical Research and the Federation of European Biochemical Societies (FEBS) Letters
http://newhope360.com/
alths-optiberry-show
No comments:
Post a Comment